Literature DB >> 3407968

Neurologic outcome in rats following incomplete cerebral ischemia during halothane, isoflurane, or N2O.

V L Baughman1, W E Hoffman, D J Miletich, R F Albrecht, C Thomas.   

Abstract

Using rats in which incomplete cerebral ischemia was induced, the authors evaluated the effects of halothane (H) and isoflurane (I) on neurologic outcome compared to nitrous oxide (N2O) controls. Incomplete cerebral ischemia was produced by right carotid artery occlusion combined with hemorrhagic hypotension. Neurologic outcome was evaluated using a graded deficit score from 0 to 5 (0 = normal, 5 = death associated with stroke). Two levels of cerebral ischemia were tested. At moderate ischemia with hypotension of 30 mmHg, an FIO2 of 0.3, and ischemic periods of 30 or 45 min, N2O produced a deficit of 4.7-5.0 and a mortality rate of 90-100%. In contrast, halothane (1 MAC) and isoflurane (1 MAC) resulted in similar deficit scores (H = 1.1-1.8, I = 1.4-1.6) and mortality rates (H = 17-30%, I = 17-20%). Cerebral blood flow (CBF) measured with radioactive microspheres showed a 60-65% decrease in the ischemic hemisphere at this level of hypotension. With severe ischemia with hypotension = 25 mmHg, FIO2 = 0.2, and a 30-min period of ischemia, deficit scores increased to 3.0 and 3.9 with 1 MAC halothane and 1 MAC isoflurane, respectively. Mortality rates also increased to 40% with halothane and 70% with isoflurane. Increasing the concentration of halothane or isoflurane to 2 MAC did not significantly improve outcome. Brain histology demonstrated extensive neuronal damage in striatal, hippocampal, and neocortical regions of N2O control treated rats, and less damage with little difference between H- and I-treated rats at each level of ischemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407968     DOI: 10.1097/00000542-198808000-00007

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  21 in total

1.  Simple model of forebrain ischemia in mouse.

Authors:  Mitch Onken; Stephanie Berger; Tibor Kristian
Journal:  J Neurosci Methods       Date:  2011-11-28       Impact factor: 2.390

Review 2.  Perioperative stroke. Part I: General surgery, carotid artery disease, and carotid endarterectomy.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

Review 3.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

4.  Effect of nitrous oxide use on long-term neurologic and neuropsychological outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery.

Authors:  Jeffrey J Pasternak; Diana G McGregor; William L Lanier; Darrell R Schroeder; Deborah A Rusy; Bradley Hindman; William Clarke; James Torner; Michael M Todd
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

Review 5.  Changing practices in neuroanaesthesia.

Authors:  J C Drummond
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

6.  Dose-dependent influence of sevoflurane anesthesia on neuronal survival and cognitive outcome after transient forebrain ischemia in Sprague-Dawley rats.

Authors:  Irina Lasarzik; Rüdiger R Noppens; Thorsten Wolf; Henrike Bauer; Clara Luh; Christian Werner; Kristin Engelhard; Serge C Thal
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

7.  Effect of halothane in cortical cell cultures exposed to N-methyl-D-aspartate.

Authors:  J P Beirne; R D Pearlstein; G W Massey; D S Warner
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

8.  Guidelines for using mouse global cerebral ischemia models.

Authors:  Tibor Kristian; Bingren Hu
Journal:  Transl Stroke Res       Date:  2012-12-14       Impact factor: 6.829

9.  Early stimulation treatment provides complete sensory-induced protection from ischemic stroke under isoflurane anesthesia.

Authors:  Christopher C Lay; Nathan Jacobs; Aneeka M Hancock; Yi Zhou; Ron D Frostig
Journal:  Eur J Neurosci       Date:  2013-04-16       Impact factor: 3.386

10.  Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.

Authors:  Zhihong Chen; Walid Jalabi; Karl B Shpargel; Kenneth T Farabaugh; Ranjan Dutta; Xinghua Yin; Grahame J Kidd; Cornelia C Bergmann; Stephen A Stohlman; Bruce D Trapp
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.